H. Boutin et al., Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice, STROKE, 30(6), 1999, pp. 1271-1277
Background and Purpose-Neuroprotection studies have demonstrated the involv
ement of opioids in ischemia, and we have previously demonstrated alteratio
ns in B-max of opioidergic receptors after 2 post-MCAO time points in mice.
Methods-In the present Study, we have investigated in a detailed manner the
postischemic time course of variations in [H-3]diprenorphine (nonselective
), [H-3]DAMGO (mu), [H-3]DADLE (delta), and [H-3]U69593 (kappa) relative bi
nding densities after focal cerebral ischemia (0 to 48 hours) in mice.
Results-In frontoparietal cortices, our results demonstrate decreases in (1
) delta receptor densities at 1 to 3 hours after MCAO, (2) mu and nonselect
ive binding sites at 6 to 12 hours after MCAO, add (3) kappa receptor densi
ties between 6 and 24 hours after MCAO. In the rostral part of the infarct
border zone, a decrease in delta-receptors was found concomitant with the e
xtension of the infarct core; conversely, the decrease in delta-receptors a
ppeared before (6 to 12 hours) macroscopic histological damage, which occur
red between 12 hours and 24 hours after MCAO in the caudal part of this are
a. In this frontier, mu- and especially kappa-binding sites were decreased
later (12 to 48 hours after MCAO).
Conclusions-These differential alterations in opioidergic receptors could b
e due to the selective sublocalization of receptors, postsynaptically on co
rtical interneurons for mu- and delta-receptors versus presynaptically on c
ortical afferent pathways for the kappa subtype. Further, our results sugge
st that delta- and mu-opioidergic receptors could be markers of infarct ext
ension and neuronal death; the study of [H-3]diprenorphine and selective bi
nding sites argues in favor of the use of receptor-specific ligands. Finall
y, the relative preservation of kappa-receptors might be correlated with th
e neuroprotective role of kappa-agonists, as previously reported.